£330m research base for drug firm

Press Association
Updated
Astra Zenica
Astra Zenica

Drug group AstraZeneca said plans for a new research base in Cambridge will boost the chances of Britain discovering the next generation of medicines.

The group revealed it will build a new £330 million research and development (R&D) site on Cambridge Biomedical Campus in the south of the city by 2016, employing about 2,000 staff.
%VIRTUAL-SkimlinksPromo%

Advertisement